GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Humankind Investments LLC

Humankind Investments LLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,876 shares of the company’s stock after acquiring an additional 1,350 shares during the period. Humankind Investments LLC’s holdings in GE HealthCare Technologies were worth $1,398,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of GEHC. CoreFirst Bank & Trust acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at $25,000. Runnymede Capital Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at $28,000. LGT Financial Advisors LLC increased its position in GE HealthCare Technologies by 46.2% during the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company’s stock worth $30,000 after purchasing an additional 123 shares in the last quarter. Accredited Wealth Management LLC acquired a new position in GE HealthCare Technologies in the 4th quarter valued at about $30,000. Finally, Bank of Jackson Hole Trust purchased a new position in GE HealthCare Technologies in the 4th quarter valued at about $32,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on GEHC shares. Piper Sandler cut their price objective on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an “overweight” rating for the company in a research report on Wednesday, April 23rd. Wells Fargo & Company reduced their price target on GE HealthCare Technologies from $103.00 to $89.00 and set an “overweight” rating on the stock in a research note on Thursday, May 1st. The Goldman Sachs Group lowered their price objective on GE HealthCare Technologies from $94.00 to $82.00 and set a “buy” rating for the company in a research report on Thursday, May 1st. Morgan Stanley decreased their price target on GE HealthCare Technologies from $86.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Finally, Citigroup dropped their price objective on shares of GE HealthCare Technologies from $105.00 to $86.00 and set a “buy” rating for the company in a research note on Wednesday, April 30th. Three investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $88.27.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $69.87 on Friday. The firm has a fifty day moving average of $72.49 and a 200-day moving average of $80.64. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $31.99 billion, a P/E ratio of 16.14, a PEG ratio of 3.19 and a beta of 1.21.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $4.78 billion for the quarter, compared to analyst estimates of $4.66 billion. During the same period last year, the company posted $0.90 earnings per share. The firm’s revenue was up 2.7% compared to the same quarter last year. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.20%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.95%.

GE HealthCare Technologies declared that its board has approved a share repurchase program on Wednesday, April 30th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 3.1% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s management believes its stock is undervalued.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.